Elevance Health, Inc (ELV)

$441.9

-5.38

(-1.2%)▲

Live

star icon

Elevance Health Inc is a healthcare company that leverages data analytics and artificial intelligence to improve patient outcomes and reduce healthcare costs.

Insights on Elevance Health, Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 39.92B → 43.67B (in $), with an average increase of 4.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 1.98B → 1.85B (in $), with an average decrease of 6.7% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 3.5% return, outperforming this stock by 5.6%

  • Vs CI

    In the last 3 years, The Cigna Corp has given 76.7% return, outperforming this stock by 4.5%

Performance

  • $440.89
    $445.87
    $441.90
    downward going graph

    0.23%

    Downside

    Day's Volatility :1.12%

    Upside

    0.89%

    downward going graph
  • $410.63
    $542.88
    $441.90
    downward going graph

    7.08%

    Downside

    52 Weeks Volatility :24.36%

    Upside

    18.6%

    downward going graph

Returns

PeriodElevance Health, IncSector (Health Care)S&P500
3 Months
1.63%
-1.3%
-2.2%
6 Months
-1.95%
1.8%
6.8%
1 Year
-2.08%
5.6%
18.1%
3 Years
72.17%
24.9%
28.9%

Highlights

Market Capitalization
104.8B
Book Value
$161.98
Dividend Share
5.52
Dividend Yield
1.32%
Earnings Per Share (EPS)
26.84
PE Ratio
16.57
PEG Ratio
1.38
Wall Street Target Price
569.78
Profit Margin
3.89%
Operating Margin TTM
5.67%
Return On Assets TTM
5.59%
Return On Equity TTM
17.43%
Revenue TTM
165.7B
Revenue Per Share TTM
696.29
Quarterly Revenue Growth YOY
13.0%
Gross Profit TTM
40.1B
EBITDA
10.6B
Diluted Eps TTM
26.84
Quarterly Earnings Growth YOY
0.16
EPS Estimate Current Year
32.93
EPS Estimate Next Year
37.01
EPS Estimate Current Quarter
8.8
EPS Estimate Next Quarter
8.43

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 28 Wall street analysts offering stock ratings for Elevance Health, Inc(by analysts ranked 0 to 5 stars)
Based on 28 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
24
24
23
Hold
4
4
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 28.94%

Current $441.90
Target $569.78

Company Financials

FY17Y/Y Change
Revenue
90.0B
↑ 6.1%
Net Income
3.8B
↑ 55.59%
Net Profit Margin
4.27%
↑ 1.36%
FY18Y/Y Change
Revenue
92.1B
↑ 2.29%
Net Income
3.8B
↓ 2.41%
Net Profit Margin
4.07%
↓ 0.2%
FY19Y/Y Change
Revenue
104.2B
↑ 13.15%
Net Income
4.8B
↑ 28.19%
Net Profit Margin
4.61%
↑ 0.54%
FY20Y/Y Change
Revenue
121.9B
↑ 16.94%
Net Income
4.6B
↓ 4.89%
Net Profit Margin
3.75%
↓ 0.86%
FY21Y/Y Change
Revenue
138.6B
↑ 13.76%
Net Income
6.1B
↑ 33.51%
Net Profit Margin
4.4%
↑ 0.65%
FY22Y/Y Change
Revenue
156.6B
↑ 12.95%
Net Income
6.0B
↓ 1.29%
Net Profit Margin
3.85%
↓ 0.55%
Q1 FY22Q/Q Change
Revenue
38.1B
↑ 4.14%
Net Income
1.8B
↑ 58.75%
Net Profit Margin
4.74%
↑ 1.63%
Q2 FY22Q/Q Change
Revenue
38.6B
↑ 1.41%
Net Income
1.7B
↓ 8.42%
Net Profit Margin
4.28%
↓ 0.46%
Q3 FY22Q/Q Change
Revenue
39.9B
↑ 3.38%
Net Income
1.6B
↓ 2.42%
Net Profit Margin
4.04%
↓ 0.24%
Q4 FY22Q/Q Change
Revenue
39.9B
↓ 0.03%
Net Income
949.0M
↓ 41.17%
Net Profit Margin
2.38%
↓ 1.66%
Q1 FY23Q/Q Change
Revenue
42.2B
↑ 5.62%
Net Income
2.0B
↑ 109.59%
Net Profit Margin
4.72%
↑ 2.34%
Q2 FY23Q/Q Change
Revenue
43.7B
↑ 3.56%
Net Income
1.9B
↓ 6.69%
Net Profit Margin
4.25%
↓ 0.47%
FY17Y/Y Change
Total Assets
70.5B
↑ 8.38%
Total Liabilities
44.0B
↑ 10.14%
FY18Y/Y Change
Total Assets
71.6B
↑ 1.46%
Total Liabilities
43.0B
↓ 2.29%
FY19Y/Y Change
Total Assets
77.5B
↑ 8.22%
Total Liabilities
45.7B
↑ 6.26%
FY20Y/Y Change
Total Assets
86.6B
↑ 11.83%
Total Liabilities
53.4B
↑ 16.82%
FY21Y/Y Change
Total Assets
97.5B
↑ 12.52%
Total Liabilities
61.3B
↑ 14.82%
FY22Y/Y Change
Total Assets
102.8B
↑ 5.45%
Total Liabilities
66.5B
↑ 8.37%
Q1 FY22Q/Q Change
Total Assets
100.5B
↑ 3.1%
Total Liabilities
64.5B
↑ 5.09%
Q2 FY22Q/Q Change
Total Assets
100.9B
↑ 0.39%
Total Liabilities
65.0B
↑ 0.86%
Q3 FY22Q/Q Change
Total Assets
103.0B
↑ 2.13%
Total Liabilities
67.0B
↑ 3.03%
Q4 FY22Q/Q Change
Total Assets
102.8B
↓ 0.25%
Total Liabilities
66.5B
↓ 0.77%
Q1 FY23Q/Q Change
Total Assets
109.0B
↑ 6.1%
Total Liabilities
71.6B
↑ 7.7%
Q2 FY23Q/Q Change
Total Assets
109.2B
↑ 0.12%
Total Liabilities
70.9B
↓ 1.01%
FY17Y/Y Change
Operating Cash Flow
4.2B
↑ 30.59%
Investing Cash Flow
-5.1B
↑ 888.99%
Financing Cash Flow
426.9M
↓ 158.25%
FY18Y/Y Change
Operating Cash Flow
3.8B
↓ 8.55%
Investing Cash Flow
-1.3B
↓ 75.23%
Financing Cash Flow
-2.2B
↓ 624.95%
FY19Y/Y Change
Operating Cash Flow
6.1B
↑ 58.37%
Investing Cash Flow
-2.8B
↑ 121.76%
Financing Cash Flow
-2.3B
↑ 1.12%
FY20Y/Y Change
Operating Cash Flow
10.7B
↑ 76.34%
Investing Cash Flow
-7.3B
↑ 162.32%
Financing Cash Flow
-2.6B
↑ 13.28%
FY21Y/Y Change
Operating Cash Flow
8.4B
↓ 21.74%
Investing Cash Flow
-9.6B
↑ 31.59%
Financing Cash Flow
423.0M
↓ 116.48%
FY22Y/Y Change
Operating Cash Flow
8.4B
↑ 0.42%
Investing Cash Flow
-4.6B
↓ 52.69%
Financing Cash Flow
-1.3B
↓ 411.58%
Q1 FY22Q/Q Change
Operating Cash Flow
2.5B
↑ 51.97%
Investing Cash Flow
-1.6B
↑ 63.35%
Financing Cash Flow
322.0M
↓ 124.49%
Q2 FY22Q/Q Change
Operating Cash Flow
2.5B
↓ 3.5%
Investing Cash Flow
-2.0B
↑ 28.26%
Financing Cash Flow
-127.0M
↓ 139.44%
Q3 FY22Q/Q Change
Operating Cash Flow
4.9B
↑ 100.82%
Investing Cash Flow
-1.2B
↓ 38.39%
Financing Cash Flow
-1.3B
↑ 888.19%
Q4 FY22Q/Q Change
Operating Cash Flow
8.4B
↑ 70.57%
Investing Cash Flow
-4.6B
↑ 265.68%
Financing Cash Flow
-1.3B
↑ 5.02%
Q1 FY23Q/Q Change
Operating Cash Flow
6.5B
↓ 22.98%
Investing Cash Flow
-3.2B
↓ 30.18%
Financing Cash Flow
-531.0M
↓ 59.71%
Q2 FY23Q/Q Change
Operating Cash Flow
8.4B
↑ 30.14%
Investing Cash Flow
-3.9B
↑ 21.11%
Financing Cash Flow
-2.0B
↑ 269.3%

Technicals Summary

Sell

Neutral

Buy

Elevance Health, Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Elevance Health, Inc
Elevance Health, Inc
-2.3%
-1.95%
-2.08%
72.17%
61.94%
The Cigna Corp
The Cigna Corp
3.08%
14.29%
3.48%
76.69%
37.64%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
3.5%
9.33%
0.25%
67.71%
89.56%
Cvs Health Corporation
Cvs Health Corporation
4.32%
-5.48%
-27.79%
21.71%
-11.91%
Humana Inc.
Humana Inc.
2.89%
1.95%
0.85%
23.34%
46.33%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Elevance Health, Inc
Elevance Health, Inc
16.57
16.57
1.38
32.93
0.17
0.06
0.01
161.98
The Cigna Corp
The Cigna Corp
13.29
13.29
1.22
24.81
0.15
0.03
0.02
153.69
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
22.85
22.85
1.66
24.85
0.25
0.07
0.01
88.84
Cvs Health Corporation
Cvs Health Corporation
32.72
32.72
1.36
8.59
0.04
0.04
0.03
56.73
Humana Inc.
Humana Inc.
18.37
18.37
1.28
28.3
0.21
0.06
0.01
135.86
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Elevance Health, Inc
Elevance Health, Inc
Buy
$104.8B
61.94%
16.57
3.89%
The Cigna Corp
The Cigna Corp
Buy
$85.9B
37.64%
13.29
3.57%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$472.5B
89.56%
22.85
6.06%
Cvs Health Corporation
Cvs Health Corporation
Buy
$91.9B
-11.91%
32.72
0.83%
Humana Inc.
Humana Inc.
Buy
$61.2B
46.33%
18.37
3.42%

Institutional Holdings

  • Vanguard Group Inc

    9.05%

  • BlackRock Inc

    8.65%

  • T. Rowe Price Associates, Inc.

    5.14%

  • State Street Corporation

    4.66%

  • Wellington Management Company LLP

    3.11%

  • Capital Research & Mgmt Co - Division 3

    1.99%

Corporate Announcements

  • Elevance Health, Inc Dividends March,2023

    In the quarter ending March,2023. Elevance Health, Inc has declared dividend of $1.48

    Read More

Company Information

Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.

Organization
Elevance Health, Inc
Employees
102300
CEO
Ms. Gail Koziara Boudreaux
Industry
Healthcare

Discover More

FAQs